The Latest Breaking News from ABBV

Warren Buffett’s value investing strategy has paid off, as its investment firm Berkshire Hathaway (BRK.A) has outperformed the broader market. Recently, the billionaire has become worther than Meta Platforms (FB) founder Mark Zuckerberg. Hence, we believe that the Berkshire Hathaway holdings AbbVie (ABBV), Bristol-Myers Squibb (BMY), and DaVita (DVA) might…

AbbVie Inc (NYSE: ABBV) reports 

Annual inflation has hit multi-year highs in December. Benchmarks are currently in a correction mode, and economists expect the Fed to come up with a rate hike very soon. Given this volatile environment, the mega-cap tech stocks Microsoft (MSFT) and Alphabet (GOOGL) might be an ideal hedge against inflation. Also,…

A whale with a lot of money to spend has taken a noticeably bearish stance on AbbVie. Looking at options history for AbbVie (NYSE:ABBV) we detected 19 strange trades.

AbbVie (NYSE:ABBV) has outperformed the market over the past 5 years by 2.43% on an annualized basis.

As the stock market is expected to remain volatile owing to the anticipated interest rate hikes to control inflation, it could be wise to bet on fundamentally strong dividend-yielding stocks AbbVie (ABBV), Philip Morris (PM), and Vector Group (VGR) for securing a steady income stream. These stocks are rated ‘Buy’…

The benchmark indexes witnessed a bull run in 2021, with numerous stocks soaring to record high price levels which were not in sync with their fundamentals. Shares of Electric vehicle companies Rivian Automotive (RIVN), Lucid Group (LCID), and NIO (NIO) hit their record highs as EVs have been dubbed as…

The